Anaplastic Large Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Anaplastic Large Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies [Phase 1]
Phase I open-label dose-finding study of SGN-35 (brentuximab vedotin) for CD30-positive hematologic malignancies, including non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies [Phase 1]
An early-phase Phase I dose-escalation study of Brentuximab vedotin (SGN-35) alone and in combination with gemcitabine for CD30-positive mal…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Cardiac Safety Study of Brentuximab Vedotin (SGN-35) [Phase 1]
Phase 1 cardiac safety study of brentuximab vedotin (SGN-35) has completed, providing early safety data in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors [Phase 1]
Phase 1 trial evaluating RO4929097 in combination with capecitabine in patients with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study [Phase 2]
Phase 2 trial update of brentuximab vedotin in patients who previously participated in a brentuximab vedotin study, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma [Phase 1]
A Phase 1 safety trial evaluating XmAb2513 for Hodgkin lymphoma and Anaplastic Large Cell Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 2]
This update reports results from a Phase 2 trial of ixabepilone in relapsed or refractory aggressive non-Hodgkin lymphoma across multiple su…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction [Phase 1]
Phase 1 trial of vorinostat in adults with metastatic or unresectable solid tumors or lymphoma and liver dysfunction has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating the combination of tanespimycin and bortezomib in adults with advanced solid tumors or lymphomas; the study was ter…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: FAU in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial evaluating FAU in patients with advanced solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma [Phase 1, Phase 2]
A phase 1/2 trial assessing ICE chemotherapy (Ifosfamide, Carboplatin, Etoposide) with Brentuximab vedotin (SGN-30) in young patients with r…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 study evaluating the combination of bortezomib and azacitidine in adults with relapsed or refractory T-cell lymphomas; the trial is …
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating SGN-30 with combination chemotherapy in newly diagnosed anaplastic large cell lymphoma; the study w…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma [Phase 3]
A phase 3 trial comparing two chemotherapy regimens for advanced anaplastic large cell lymphoma, using vincristine or vinblastine, has poste…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial evaluating Triapine (3-AP) in combination with gemcitabine in patients with advanced solid tumors or lymphoma has completed. I…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma [Phase 1]
Phase 1 clinical trial evaluating an unspecified monoclonal antibody therapy for patients with refractory anaplastic large cell lymphoma or …
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of tanespimycin (17-allylamino-17-demethoxygeldanamycin) and bortezomib in relapsed or ref…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating PXD101 in combination with 17-N-allylamino-17-demethoxygeldanamycin for metastatic or unresectable solid tumors o…
-
CLINICAL_TRIALS withdrawal · 2013-05-15Clinical Trial Update: Denileukine Diftitox for Relapsed ALCL [Phase 2]
A Phase 2 trial evaluating denileukin diftitox (Ontak) for relapsed Anaplastic Large-Cell Lymphoma has been withdrawn. The study sponsor is …
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
A Phase 1 study evaluating belinostat (PXD101) in combination with bortezomib in adults with advanced solid tumors or lymphomas has complete…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Sorafenib in adults with recurrent non-Hodgkin lymphoma, including Anaplastic Large Cell Lymphoma, Diffuse Large B-…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]
This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating bevacizumab in patients with various non-Hodgkin lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial evaluating 17-DMAG (alvespimycin), an HSP90 inhibitor, in patients with metastatic or unresectable solid tumors or ly…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for cilengitide in patients with advanced solid tumors or lymphoma, with the study status reported as completed.